Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen S Lichter

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
JAMA|May 3, 2017
Conflict of Interest and the Integrity of the Medical ProfessionAllen S Lichter
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2018
From Choosing Wisely to Using Wisely: Increasing the Value of Cancer Care Through Clinical ResearchAllen S Lichter
Clinical Advances in Hematology & Oncology : H&O|September 27, 2017
The value in cancer care consortium: addressing financial toxicityAllen S Lichter
The American Journal of Managed Care|May 31, 2012
Oncology hit hard by SGR debacle. An interview with Allen S. LichterAllen S Lichter
The Oncologist|February 14, 2012
Relentless progress: ASCO respondsAllen S Lichter
JAMA|November 29, 2012
Toward a harmonized and centralized conflict of interest disclosure: progress from an IOM initiativeAllen S Lichter, Ross McKinney
Cancer Journal (Sudbury, Mass.)|August 1, 2020
Introduction by the Guest EditorsMark J Ratain, Allen S Lichter
Journal of Vascular Surgery|August 30, 2011
The new CMSS code for interactions with companies managing relationships to minimize conflictsNorman B Kahn, Allen S Lichter,
JAMA Oncology|June 21, 2019
Interventional Pharmacoeconomics-A New Discipline for a Cost-Constrained EnvironmentMark J Ratain, Daniel A Goldstein, Allen S Lichter
Blood Advances|July 11, 2022
The dosing of ibrutinib and related Bruton's tyrosine kinase inhibitors: eliminating the use of brute forceMark J Ratain, Ian F Tannock, Allen S Lichter
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
JAMA|May 3, 2017
Conflict of Interest and the Integrity of the Medical ProfessionAllen S Lichter
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2018
From Choosing Wisely to Using Wisely: Increasing the Value of Cancer Care Through Clinical ResearchAllen S Lichter
Clinical Advances in Hematology & Oncology : H&O|September 27, 2017
The value in cancer care consortium: addressing financial toxicityAllen S Lichter
The American Journal of Managed Care|May 31, 2012
Oncology hit hard by SGR debacle. An interview with Allen S. LichterAllen S Lichter
The Oncologist|February 14, 2012
Relentless progress: ASCO respondsAllen S Lichter
JAMA|November 29, 2012
Toward a harmonized and centralized conflict of interest disclosure: progress from an IOM initiativeAllen S Lichter, Ross McKinney
Cancer Journal (Sudbury, Mass.)|August 1, 2020
Introduction by the Guest EditorsMark J Ratain, Allen S Lichter
Journal of Vascular Surgery|August 30, 2011
The new CMSS code for interactions with companies managing relationships to minimize conflictsNorman B Kahn, Allen S Lichter,
JAMA Oncology|June 21, 2019
Interventional Pharmacoeconomics-A New Discipline for a Cost-Constrained EnvironmentMark J Ratain, Daniel A Goldstein, Allen S Lichter
Blood Advances|July 11, 2022
The dosing of ibrutinib and related Bruton's tyrosine kinase inhibitors: eliminating the use of brute forceMark J Ratain, Ian F Tannock, Allen S Lichter
Pageof 3